🟢 Strong Evidence
The U.S. Food and Drug Administration (FDA) has expanded a recall of reprocessed electrophysiology and ultrasound catheters manufactured by Medline Industries due to contamination with residual particulates. These retained particles pose a risk of serious patient harm, including infection, arterial or venous embolism, and thrombosis, according to the FDA’s medical device recall database.
Key takeaways
- Reprocessed catheters from Medline Industries may retain particulate matter after sterilisation
- FDA identifies residual particles as a potential source of infection, embolism, and thrombosis
- Hospitals and outpatient facilities should verify equipment stock and follow FDA guidance immediately
Reprocessed Medical Device Recall Risk Hierarchy
Potential patient harms from retained particulate contamination in reprocessed catheters
Source: FDA Medical Device Recall Database | Georgian Medical Journal News
Scope of the recall and affected products
The FDA’s recall notice identifies reprocessed electrophysiology catheters and ultrasound catheters distributed by Medline Industries as the products in question. The expansion of this recall suggests that previous containment efforts were insufficient and that additional batches may have been affected by inadequate cleaning protocols during the reprocessing procedure. Reprocessed medical devices undergo cleaning, sterilisation, and testing after initial use, but lapses in any of these steps can compromise patient safety.
Healthcare facilities using these devices should immediately consult the FDA’s detailed product listing to verify whether their inventory includes recalled catheters, and should segregate and remove affected items from clinical use.
Clinical implications and patient safety risk
Residual particulates in catheters present acute and serious clinical risks. When a contaminated catheter is placed in a patient’s vasculature, particulates can dislodge and travel through blood vessels, potentially causing thrombosis (blood clot formation) or embolism. Additionally, particles may harbour bacterial or fungal contaminants, leading to catheter-related bloodstream infections—a known driver of morbidity and mortality in hospitalised patients. The U.S. Centers for Disease Control and Prevention (CDC) reports that catheter-related infections extend hospital stays and increase healthcare costs significantly.
Electrophysiology catheters are used in arrhythmia diagnosis and ablation, where precise, unobstructed navigation is critical. Ultrasound catheters are used in diagnostic and interventional procedures where image quality depends on uncontaminated transducers. Particulate contamination compromises both safety and clinical efficacy. Healthcare quality and safety protocols require immediate escalation of any identified recalled devices.
Reprocessed catheters contaminated with residual particulates carry a high risk of infection, arterial or venous embolism, and thrombosis, according to the FDA recall notice.
— U.S. Food and Drug Administration (Medical Device Recalls and Alerts, 2025)
What healthcare facilities must do now
Hospital quality and safety teams, procurement departments, and clinical engineering units must act immediately. The FDA’s recall page contains a detailed product list with lot numbers and serial number ranges. Facilities should cross-reference their inventory against this list, document findings, and remove affected devices from service. Any catheters distributed before the recall date that have already been used should be flagged in patient records, and clinicians should be alerted to monitor those patients for signs of thrombosis, embolism, or infection.
Medline Industries and healthcare facility leadership should establish a communication protocol to ensure that all staff who handle, sterilise, or use these devices are informed. For additional guidance, facilities can contact the FDA’s MedWatch programme, which tracks adverse events linked to recalled devices and can provide epidemiological data on patient harm.
What this means
Frequently asked questions
How do I know if my facility has affected catheters?
Check the FDA’s product listing by lot number and serial number range. Contact your medical device procurement team and facility engineers immediately to cross-reference your inventory. If you cannot verify status, treat devices as potentially affected and remove from service.
What should patients do if they received a procedure with a recalled catheter?
Contact your healthcare provider to determine whether a recalled device was used in your procedure. Your clinician may recommend follow-up imaging or monitoring depending on the type of procedure and your risk factors. Report any new symptoms such as fever, chest pain, leg swelling, or shortness of breath to your doctor immediately, as these may indicate complications.
Is reprocessing of medical devices safe?
Yes, when performed correctly by accredited reprocessing facilities following FDA guidelines. However, this recall demonstrates that lapses in cleaning and sterilisation procedures can occur. The FDA provides detailed standards for reprocessing, and facilities should verify that their reprocessing partners meet these standards. For single-use devices that are reprocessed, extra caution is warranted.
The expansion of Medline Industries’ catheter recall serves as a critical reminder that even widely distributed medical devices can fail quality standards. Healthcare systems must maintain vigilant post-market surveillance and rapid response protocols to protect patients from harm. Clinical updates and safety alerts should be communicated to all relevant personnel within hours of publication. Manufacturers, regulators, and healthcare facilities share responsibility for maintaining the integrity of the medical device supply chain.
Source: FDA Medical Device Recalls and Early Alerts — Catheter Recall Expansion: Medline Industries
Was this article helpful?
Related Coverage
